PHILADELPHIA--(BUSINESS WIRE)--TransCelerate BioPharma Inc. today announced the availability of an enhanced technology enabled Common Protocol Template (CPT). This update to the CPT is in alignment ...
In order to address the specific details and regulatory requirements present in a retrospective medical chart review, the UB IRB recently created a new Protocol template: the HRP-503R. In order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback